Cartesian Therapeutics
RNAC
$26.43
Share price
0.34%
Change (1 day)
2,281.08%
Change (1 year)
Categories
Cartesian Therapeutics (RNAC) - P/B ratio
P/B ratio as of May 2024 : -1.06
According to Cartesian Therapeutics's latest financial reports the company has a price-to-book ratio of -1.06.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Cartesian Therapeutics - P/B ratio (from 2016 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -0.2536 | -113.76% |
| 2022-12-31 | 1.84 | -89.7% |
| 2021-12-31 | 17.9 | -198.4% |
| 2020-12-31 | -18.2 | -174.33% |
| 2019-12-31 | 24.5 | -321.77% |
| 2018-12-31 | -11.0 | -360.88% |
| 2017-12-31 | 4.23 | -25.5% |
| 2016-12-31 | 5.68 | |
| 2015-12-31 | N/A |